Skip to main content

Information updates

ASCIA e-training feedback surveys - February 2023

ASCIA anaphylaxis, allergy and immunodeficiency e-training courses for health professional, schools, children’s education/care services and community are:

  • Accessible - online and free of charge
  • Consistent - used throughout Australia and New Zealand
  • Evidence based - courses are regularly reviewed and updated, in response to requests, recommendations, changes in clinical and academic expert consensus, new published literature and product updates..

To help ASCIA to continue improving these courses a short survey is now included at the end of each of the courses, which will only take a few minutes to complete. All information collected will be anonymous.  Improvements made as a result of feedback will be undertaken as part of ASCIA's involvement in the National Allergy Council (NAC) Share Care Model (SCM) project and the NAC Schools/Childcare project

ASCIA anaphylaxis e-training for schools, children’s education/care services and community 
Since 2010 ASCIA has provided accessible, consistent and evidence-based anaphylaxis e-training courses for schools, children’s education/care services and community, which can be accessed at:
 
ASCIA anaphylaxis and allergy e-training for health professionals
Since 2011 ASCIA has provided anaphylaxis, food allergy, allergic rhinitis and allergen immunotherapy e-training courses for health professionals, which can be accessed at
 
ASCIA immunodeficiency e-training for health professionals
In 2022 ASCIA developed two new e-training courses for health professionals about immunoglobulin replacement therapy (IRT) and hereditary angioedema (HAE), which can be accessed at https://immunodeficiency.ascia.org.au/

ASCIA pharmacist e-training 
Since 2012 ASCIA has provided anaphylaxis, food allergy and allergic rhinitis e-training courses for pharmacists, which can be accessed at 

This news item was issued on 15 February 2023 by Jill Smith, CEO of ASCIA, the peak professional body for clinical immunology and allergy in Australia and New Zealand.